Did you know?

You can download a free poster of expert poster tips for your lab wall!

Browse
Categories

Faculty Conference Society

Diabetes & Endocrinology

Welcome to F1000 Posters. You can browse by Faculty or Section (subspeciality) listed in the left-hand column, as well as by conference or society.

As well as providing a summary of the work alongside the poster or slide presentation, links to F1000 Faculty Member evaluations and related research articles from the authors are included, if applicable. Please use the information in these posters/slide presentations responsibly, and include the full citation if you wish to reuse any of the material. Please note that most work on this site is preliminary in nature and has not been reviewed.

  1. Prenatal Ad.VEGF gene therapy increases

    Prenatal Ad.VEGF gene therapy increases fetal growth velocity and expression of VEGF receptors in an ovine paradigm of fetal growth restriction

    D Carr, R Aitken, J Milne, D Peebles, ..., J Martin, I Zachary, J Wallace, A David F1000 Posters 2012, 3: 231 (slide presentation)

    Summary | Slide Presentation [5.04 MB] | Evaluation

  2. Mycobacterial Hsp65 can cross react

    Mycobacterial Hsp65 can cross react with human auto-antibodies and induce cytokine responses relevant to type I and type II diabetes

    P Sandhya Rani, N Ahmed F1000 Posters 2012, 3: 142 (poster)

    Summary | Poster [3.13 MB]

  3. Embryonic GABA ~B~

    Embryonic GABA B receptor blockade alters adult hypothalamic structure, and anxiety- and depression-like behaviors in mice

    M Stratton, T Budefeld, G Majdic, S Tobet F1000 Posters 2012, 3: 19 (poster)

    Summary | Poster [2.41 MB]

  4. Revisiting the threshold values of

    Revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of the Polycystic Ovary (PCO)

    D Dewailly, H Gronier, E Poncelet, G Robin, ..., M Leroy, P Pigny, A Duhamel, S Catteau-Jonard F1000 Posters 2011, 2: 1880 (slide presentation)

    Summary | Slide Presentation [1.48 MB]

  5. The BeAM factor: an

    The BeAM factor: an easy-to-determine, objective clinical indicator for deciding when to add prandial insulin to basal insulin in type 2 diabetes

    A Zisman, A Vlajnic, R Zhou F1000 Posters 2011, 2: 1839 (poster)

    Summary | Poster [547.75 KB]

  6. Adipokines leptin and adiponectin correlate

    Adipokines leptin and adiponectin correlate with matrix metalloproteinases and interleukin-6 in synovial fluid from osteoarthritis patients and enhance their production in osteoarthritic cartilage ex vivo

    K Vuolteenaho, A Koskinen, S Juslin, R Nieminen, T Moilanen, E Moilanen F1000 Posters 2011, 2: 1838 (poster)

    Summary | Poster [302.76 KB] | Evaluation

  7. _In vitro_ modeling

    In vitro modeling of microparticle production in diabetic nephropathy

    M Alkhatatbeh, L Lincz, R Thorne F1000 Posters 2011, 2: 1817 (poster)

    Summary | Poster [870.11 KB]

  8. Duration of diabetes and hypoglycemia

    Duration of diabetes and hypoglycemia rates in type 2 diabetes patients treated with insulin glargine vs NPH insulin

    G Dailey, L Aurand, SK Garg F1000 Posters 2011, 2: 1780 (poster)

    Summary | Poster [321.33 KB]

  9. The impact of glucose variability

    The impact of glucose variability on achievement of glycemic control and risk of hypoglycemia in patients with type 2 diabetes

    GE Umpierrez, A DiGenio, R Zhou, SE Inzucchi F1000 Posters 2011, 2: 1779 (poster)

    Summary | Poster [393.71 KB]

  10. Real-world clinical and economic outcomes

    Real-world clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen vs insulin detemir disposable pen in a US managed care setting

    L Xie, W Wei, C Pan, J Du, O Baser F1000 Posters 2011, 2: 1778 (poster)

    Summary | Poster [857.40 KB]

Faculty of 1000